U.S. CDC advisers recommend COVID-19 vaccine boosters for 65 and older, high risk

·1 min read
A man takes a selfie while receiving the third Pfizer-BioNTech COVID-19 vaccine from medical staff at a coronavirus vaccination center in Ramat Gan, Israel on Aug. 30.  (Oded Balilty/The Associated Press - image credit)
A man takes a selfie while receiving the third Pfizer-BioNTech COVID-19 vaccine from medical staff at a coronavirus vaccination center in Ramat Gan, Israel on Aug. 30. (Oded Balilty/The Associated Press - image credit)

An advisory panel at the U.S. Centers for Disease Control and Prevention (CDC) has recommended a booster shot of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and for some adults with underlying medical conditions.

The vote by the group on Thursday clears the way for a booster roll-out to begin as soon as this week for millions of people who had their second dose at least six months ago.

It also follows Wednesday's emergency use authorization from the U.S. Food and Drug Administration (FDA) for a booster shot of the Pfizer vaccine for seniors 65 and up and for certain adults at a high risk of severe COVID-19.

More to come

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting